Actively Recruiting
Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)
Led by University of Aarhus · Updated on 2021-09-24
55
Participants Needed
1
Research Sites
469 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This protocol aims to determine toxicity and efficacy of re-irradiation for patients with recurrences from anal cancers with dose-escalated pencil beam proton therapy either pre-operative for marginally resectable recurrences or as a definitive treatment strategy (un-resectable, operation declined etc.). The over-all aim is to improve local tumor control with acceptable side effects.
CONDITIONS
Official Title
Pencil Beam Proton Therapy for Recurrences in Anal Cancer Patients Previously Treated With Radiotherapy (DACG 5)
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Recurrent anal cancer
- Biopsy confirmed squamous cell carcinoma
- Available dose plan from prior radiotherapy
- Previous radiotherapy with dose >30 Gy EQD2
- Evaluated in multidisciplinary team conferences (Herlev, Aarhus)
- Age greater than 18 years
- Performance status 0 to 2
- Adequate organ function
- Written informed consent provided
You will not qualify if you...
- Presence of distant metastases without curative treatment options (based on PET-CT)
- Unable to undergo MRI or PET-CT scans
- Unable to attend the full course of radiotherapy and outpatient follow-up
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 1 location
1
Danish Centre for Particle Therapy
Aarhus N, Aarhus, Denmark, 8200
Actively Recruiting
Research Team
C
Camilla Kronborg, MD, PhD
CONTACT
How is the study designed?
Study Type
INTERVENTIONAL
Masking
NONE
Allocation
NON_RANDOMIZED
Model
SINGLE_GROUP
Primary Purpose
TREATMENT
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here